血液凝结因子XIII活性在为出血性休克进行复苏期间的变化
Yusuke Yamada1,2, Tomohiro Abe1,3, Rina Tanohata1
1Department of Emergency and Critical Care Medicine, University of Miyazaki, Japan.
Journal of rural medicine : JRM
|April 24, 2024
概括
在出血性休克复苏期间,XIII因子 (FXIII) 的活性仍然很低. 血输血不能充分维持FXIII水平,突出了创伤护理期间控制凝血的关键差距.
科学领域:
- 创伤和紧急医疗医学
- 血液学 血液学 血液学
- 凝血科学 凝血科学
背景情况:
- 出血性休克复苏涉及复杂的生理变化.
- 在此期间,XIII因子 (FXIII) 活动的作用尚不清楚.
- 血输血是一种常见的干预措施,但它们对FXIII水平的影响尚不清楚.
研究的目的:
- 为了评估因子XIII (FXIII) 活性在出血性休克的复苏期间的变化.
- 评估血输血对这些患者的FXIII水平的影响.
主要方法:
- 在23名患有出血性休克的成年患者中进行单中心观察性研究.
- 血液样本采集在抵达 (T1),止血完成 (T2) 和第二天 (T3).
- 测量了FXIII活性和具有充足FXIII水平 (>70%) 的患者比例.
主要成果:
- 抵达时FXIII活动的中位数为53%,到第二天没有显著增加.
- 在整个复苏过程中,具有足够FXIII活性的患者比例下降 (30%在T1,34%在T2,21%在T3).
- 血输血并没有显著改善FXIII活性或具有足够水平的患者比例.
结论:
- 在出血性休克的早期阶段,XIII因子 (FXIII) 的活性不足.
- 目前的复苏策略,包括血输血,无法充分恢复或维持FXIII水平.
- 需要进一步的研究,以优化创伤患者的FXIII管理.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
7.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.3K
Coagulation
6.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
687
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687
Introduction to Hemostasis
7.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.4K
Clot Retraction and Fibrinolysis
5.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.7K
Disorders of Hemostasis
872
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
872


